Precision Medicine

The research initiative at the EIPM at WCM brings together multitalented and motivated physician-scientists and researchers from around the world that specialize in various different fields including medicine, computational biology, genomics, and biomedicine to target some of the most formidable health challenges. This multidisciplinary approach is critical to advancing treatment and speeding the handoff from discovery to clinical implementation. Our researchers are pushing scientific discoveries forward and speeding breakthroughs made in the laboratory directly to the patient’s bedside.


In the Englander Institute for Precision Medicine (EIPM), we are changing the face of how we diagnose, treat, and care for patients using a personalized approach and genomic sequencing data. Some of the most serious diseases can be traced in our genome. For these diseases, in EIPM we aim to deliver more effective treatments by identifying and characterizing genomic changes underlying genetic-based ailments. In EIPM we collaborate with clinical departments of WCM and NYP to provide a comprehensive interpretation of patient genomes and act as a permanent resource for our clinicians to make effective use of genomic data to optimize patient care. To this effort, we are channeling our efforts towards developing therapies where genomic data contribute significantly to the clinical result and offer hope for transforming health care.


Ushering in a new era at Weill Cornell Medicine for cutting-edge, translational science are the laboratory facilities located on in the Belfer Research Building, an innovative research facility located on East 69th Street in New York City. The Belfer Research Building serves as a nucleus where physician-scientists, medical educators, graduate students, and cancer researchers from WCM and around the world collaborate on the newest discoveries and cutting-edge research breakthroughs.

Clinical & Translational Science Center 1300 York Ave., Box 149 New York, NY 10065